Date | Time | Source | Headline | Symbol | Company |
09/06/2024 | 12:07PM | RNS Regulatory News | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
09/06/2024 | 6:33AM | RNS Non-Regulatory | MaxCyte, Inc. Bioprocessing Conference Participation | LSE:MXCT | Maxcyte Inc |
09/03/2024 | 10:38AM | RNS Regulatory News | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
08/29/2024 | 5:06AM | RNS Regulatory News | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
08/07/2024 | 9:10AM | Alliance News | MaxCyte reaffirms guidance as revenue jumps 24% in first half | LSE:MXCT | Maxcyte Inc |
08/07/2024 | 2:05AM | RNS Regulatory News | MaxCyte, Inc. Filing of Form 10-Q | LSE:MXCT | Maxcyte Inc |
08/07/2024 | 2:00AM | RNS Regulatory News | MaxCyte, Inc. Second Quarter and Half-Year Results | LSE:MXCT | Maxcyte Inc |
08/01/2024 | 11:31AM | RNS Regulatory News | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
07/31/2024 | 2:00AM | RNS Regulatory News | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
07/10/2024 | 4:15AM | RNS Regulatory News | MaxCyte, Inc. Notice of Results | LSE:MXCT | Maxcyte Inc |
07/09/2024 | 4:14AM | RNS Regulatory News | MaxCyte, Inc. Change of Name of Nominated Adviser and Broker | LSE:MXCT | Maxcyte Inc |
07/03/2024 | 2:00AM | RNS Regulatory News | MaxCyte, Inc. TR-1: Notification of major holdings | LSE:MXCT | Maxcyte Inc |
07/02/2024 | 6:18AM | RNS Regulatory News | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
07/02/2024 | 2:00AM | RNS Regulatory News | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
06/27/2024 | 9:34AM | RNS Regulatory News | MaxCyte, Inc. Publication of Annual Report | LSE:MXCT | Maxcyte Inc |
06/14/2024 | 2:00AM | RNS Regulatory News | MaxCyte, Inc. Grant of Options and Restricted Stock Units | LSE:MXCT | Maxcyte Inc |
06/12/2024 | 2:00AM | RNS Regulatory News | MaxCyte, Inc. Result of AGM | LSE:MXCT | Maxcyte Inc |
06/11/2024 | 6:10AM | Alliance News | IN BRIEF: MaxCyte CEO Maher Masoud buys 100,000 shares | LSE:MXCT | Maxcyte Inc |
06/11/2024 | 2:00AM | RNS Regulatory News | MaxCyte, Inc. PDMR Dealing | LSE:MXCT | Maxcyte Inc |
06/03/2024 | 10:22AM | RNS Regulatory News | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
05/29/2024 | 8:05AM | RNS Regulatory News | MaxCyte, Inc. Participation in Upcoming Investor Conference | LSE:MXCT | Maxcyte Inc |
05/22/2024 | 4:51PM | Alliance News | IN BRIEF: MaxCyte inks deal with Legend Biotech for tech supply | LSE:MXCT | Maxcyte Inc |
05/22/2024 | 8:05AM | RNS Regulatory News | MaxCyte, Inc. Signing of Strategic Platform License | LSE:MXCT | Maxcyte Inc |
05/20/2024 | 2:00AM | RNS Regulatory News | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
05/14/2024 | 9:55AM | RNS Regulatory News | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
05/08/2024 | 4:46AM | Alliance News | MaxCyte shares rise amid double-digit revenue increase | LSE:MXCT | Maxcyte Inc |
05/08/2024 | 2:05AM | RNS Regulatory News | MaxCyte, Inc. Filing of Form 10-Q | LSE:MXCT | Maxcyte Inc |
05/08/2024 | 2:00AM | RNS Regulatory News | MaxCyte, Inc. First Quarter Results | LSE:MXCT | Maxcyte Inc |
05/03/2024 | 2:00AM | RNS Regulatory News | MaxCyte, Inc. Notice of AGM | LSE:MXCT | Maxcyte Inc |
05/01/2024 | 12:04PM | RNS Regulatory News | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |